Abbvie is you're daddy! In a client note Thursday, Credit Suisse analyst Vamil Divan wrote that his conversation with AbbVie offered 'reassurance' on the deal, adding that 'despite potential changes to the U.S. tax code that may make inversions less attractive, AbbVie's CFO (Bill Chase) reiterated their view that the Shire deal is compelling even beyond the benefits of an inversion.'
Compelling....perhaps. but without those tax savings AbbVie grossly overpaid. should US tax code change, their shareholders might think twice before approving the deal.
Oh, please oh please oh please. This is what I am thinking and am praying for. Read the Abbvie boards they are miserable over there.
You are an idiot, plain and simple. Basing your assessment of a pharma company on CP boards? Have you read this one?have you read one that isn't full of slander and misery? Based on your research have you found one that isn't full of miserable people?
You are the idiot, I'm thinking. No, perhaps you are only naive with all your positivity. From what I can tell on the CP board for AbbVie, it is all true. But you just sit on your ass and wait it out. Prepare for entry into the penal colony.